慢性病贫血的研究进展

[1]	张之南,沈悌.血液病诊疗标准[M].3版.北京: 科学出版社,2007:17-19.
[2]	VALORE E V,GANZ T.Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin[J].Blood Cells Mol Dis,2008,40:132-138.
[3]	NEMETH E,TUTTLE M S,POWELSON J,et al.Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization[J].Science,2004,306:2090-2093.
[4]	THEURL I,AIGNER E,THEURL M.Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications[J].Blood,2009,113:5277-5286.
[5]	FLEMING R E.Iron and inflammation: cross-talk between pathways regulating hepcidin[J].J Mol Med,2008,86:491-494.
[6]	KALANTAR-ZADEH K,MCALLISTER C J,LEHN R S,et al.Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients[J].Am J Kidney Dis,2003,42:761-773.
[7]	李蓉生.慢性病贫血[J].中华检验医学杂志,2011,34(2):190-192.
[8]	蔡健梅,梅敏.可溶性转铁蛋白受体在缺铁性贫血中的临床应用[J].现代检验医学杂志,2010,25(5):137-139.
[9]	BARRY S S,KARI P,PAUL H C.Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: A prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index[J].Am J Hematol,2011,86:923-927.
[10]	GOODNOUGH L T,NEMETH E,GANZ T.Detection,evaluation and management of ironrestricted erythropoiesis[J].Blood,2010,116: 4754-4761.
[11]	THOMAS C,KOBOLD U,BALAN S,et al.Serum hepcidin-25 may replace the ferritin index in the Thomas plot in assessing iron status in anemic patients[J].Int J Lab Hematol,2011,33:187-193.
[12]	THEURL I,FINKENSTEDT A,SCHROLL A,et al.Growth differentiation factor 15 in anaemia of chronic disease,iron deficiency anaemia and mixed type anaemia[J].Br J Haematol,2010,148: 449-455.
[13]	BARBRA J S,KEEGAN S C,TARA L,et al.Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia[J].Blood,2010,115: 3616-3624.
[14]	LAKHAL S,SCHÖDEL J,TOWNSEND A R,et al.Regulation of type Ⅱ transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors[J].J Biol Chem,2011,286: 4090-4097.
[15]	YU P B,HONG C C,SACHIDAN-ANDAN C,et al.Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism[J].Nat Chem Biol,2008,4: 33-41.
[16]	STEINBICKER A U,SACHIDANANDAN C,VONNER A J.Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation[J].Blood,2011,117:4915-4923.
[17]	BABITT J L,HUANG F W,XIA Y,et al.Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance[J].J Clin Invest,2007,117:1933-1939.
[18]	MAURA P,DOMENICO G,NATASCIA C,et al.Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo[J].Blood,2011,117:997-1004).
[19]	SONG S N,TOMOSUGI N,KAWABATA H,et al.Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease[J].Blood,2010,116:3627-3364.
[20]	HASHIZUME M,UCHIYAMA Y,HORAI N,et al.Tocilizumab,a humanized anti-interleukin-6 receptor antibody,improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production[J].Rheumatol Int,2010,30:917-923.